← Leaderboards
Mia Hashibe
Utah State Higher Education System--University Of Utah
$7,566,803
Attributed
$11,697,457
Total exposure
13
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,697,457 · 13
By mechanism
R01$8,582,966 · 3
R21$1,121,422 · 3
UE5$1,008,870 · 1
R03$491,045 · 3
R25$310,217 · 1
T32$145,937 · 1
Top collaborators
- Sean Vahram Tavtigian5 shared
- Kolawole S Okuyemi4 shared
- Jennifer A. Doherty2 shared
- Yuan Chin Amy Lee2 shared
- Marcus M Monroe2 shared
- Nicola J Camp1 shared
- Ben A Haaland1 shared
- Yves A Lussier1 shared
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsDatabasesUtahDiagnosisPopulation DatabaseMedicareMalignant Breast NeoplasmCohortPopulation BasedNeoplasm RegistryReportingDesignLinkIncidenceUnited StatesCancer SurvivorCancer PatientComputerized Medical RecordFamily History OfBaseMalignant Neoplasm Of ProstateCaringRegistriesFollow-Up
Grant awards (33)
Identifying Cancer Recurrence with Novel Data Linkages with a Cancer Registry$648,152
R01 · FY2025 · CA
Huntsman Cancer Institute Oncological Data Science (ODSi) Training Program$145,937
T32 · FY2025 · CA
Identifying Cancer Recurrence with Novel Data Linkages with a Cancer Registry$618,197
R01 · FY2024 · CA
Long-Term Adverse Outcomes Among Rural Cancer Survivors in a Population-Based Cohort$418,355
R01 · FY2024 · CA
Identifying Cancer Recurrence with Novel Data Linkages with a Cancer Registry$639,749
R01 · FY2023 · CA · contact PI
Long-Term Adverse Outcomes Among Rural Cancer Survivors in a Population-Based Cohort$476,842
R01 · FY2023 · CA · contact PI
Utah Advanced Course on Cancer-related Health Disparities Research, Mentoring, & Leadership$310,217
R25 · FY2023 · CA
Identifying Cancer Recurrence with Novel Data Linkages with a Cancer Registry$679,495
R01 · FY2022 · CA · contact PI
Long-Term Adverse Outcomes Among Rural Cancer Survivors in a Population-Based Cohort$476,842
R01 · FY2022 · CA · contact PI
Utah Advanced Course on Mentorship and Leadership on Cancer-Related Health Disparities$314,257
UE5 · FY2022 · CA
Long-Term Adverse Outcomes Among Rural Cancer Survivors in a Population-Based Cohort$486,574
R01 · FY2021 · CA · contact PI
Utah Advanced Course on Mentorship and Leadership on Cancer-Related Health Disparities$367,199
UE5 · FY2021 · CA
Long-Term Adverse Outcomes Among Rural Cancer Survivors in a Population-Based Cohort$520,260
R01 · FY2020 · CA · contact PI
Utah Advanced Course on Mentorship and Leadership on Cancer-Related Health Disparities$327,414
UE5 · FY2020 · CA
Improving Our Understanding of Late Oral Health Effects in Head and Neck Cancer Survivors$190,625
R21 · FY2019 · DE
Exome sequencing for head and neck cancer susceptibility genes$717,394
R01 · FY2018 · DE · contact PI
Improving Our Understanding of Late Oral Health Effects in Head and Neck Cancer Survivors$228,750
R21 · FY2018 · DE
INHANCE Consortium$17,000
R13 · FY2018 · CA · contact PI
Exome sequencing for head and neck cancer susceptibility genes$713,717
R01 · FY2017 · DE · contact PI
INHANCE Consortium$20,000
R13 · FY2017 · CA · contact PI
Exome sequencing for head and neck cancer susceptibility genes$714,205
R01 · FY2016 · DE · contact PI
Population-based Cohort of Endometrial Cancer Survivors in Utah$162,038
R21 · FY2016 · CA · contact PI
Exome sequencing for head and neck cancer susceptibility genes$741,441
R01 · FY2015 · DE · contact PI
Population-based Cohort of Endometrial Cancer Survivors in Utah$194,445
R21 · FY2015 · CA · contact PI
Exome sequencing for head and neck cancer susceptibility genes$731,743
R01 · FY2014 · DE · contact PI
Head and Neck Cancer Risk Prediction Model$182,983
R21 · FY2013 · CA
Head and Neck Cancer Risk Prediction Model$162,581
R21 · FY2012 · CA
Epidemiology of testicular cancer in the Utah population$74,750
R03 · FY2012 · CA · contact PI
Epidemiology of testicular cancer in the Utah population$74,833
R03 · FY2011 · CA · contact PI
Pooled Analyses of SNPs and Risk of Head & Neck Cancer$110,345
R03 · FY2006 · DE · contact PI
Pooled Analyses of SNPs and Risk of Head &Neck Cancer$113,000
R03 · FY2005 · DE
International Head and Neck Cancer Consortium$59,400
R03 · FY2005 · CA
International Head and Neck Cancer Consortium$58,717
R03 · FY2004 · CA